🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10364+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov.
Report missing data

Showing 20 of 10364 recruiting trials

EARLY_Phase 1RecruitingNCT07007078

Efficacy of Dihydroartemisinin for Treating Acne Vulgaris

👨‍⚕️ Jingjing JIANG, MD, PhD, Fudan University📍 1 site📅 Started Jun 2025View details ↗
Enrolling by InvitationNCT07090382

Prospective Validation of the STOPSHOCK Score - Artificial Intelligence Based Predictive Scoring System to Identify the Risk of Developing Cardiogenic Shock (CS) in Patients Suffering From Acute Coronary Syndrome (ACS)

👨‍⚕️ Allan Böhm, MD, PhD, MSc, MBA, FESC, FJCS, Premedix Academy📍 1 site📅 Started Jun 2025View details ↗
NARecruitingNCT07353424

A Multicenter Randomized Clinical Trial Compared With Standard Clinical Practice to Evaluate the Efficacy of a Polyphenol-rich Salicornia Extract in the Progression of Cognitive Decline in a Cohort of Patients With Lacunar Infarcts (SALACUNAR)

🏥 Fundación Pública Andaluza para la gestión de la Investigación en Sevilla📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07085247

The Role of Cutibacterium Acnes in the Development of Degenerative Lumbar Intervertebral Disc Disease

🏥 Masaryk University📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07092358

Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta

👨‍⚕️ Zhi-Ying Wu, M.D&Ph.D, Second Affiliated Hospital of Zhejiang University School of Medicine📍 2 sites📅 Started Jun 2025View details ↗
Phase 1RecruitingNCT06980597

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

🏥 Beijing GoBroad Hospital📍 2 sites📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT07450391

EBV-AST Cell Injection for EBV-Associated Lymphoproliferative Disorders

👨‍⚕️ Daihong Liu, Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
RecruitingNCT07161882

ALG-LungCancerRegistry (SAFRO2202)

👨‍⚕️ Adda BOUNEDJAR, Professor of Medical Oncology, Frantz Fanon University Hospital, Cancer Center (CAC), Blida, Algeria📍 21 sites📅 Started Jun 2025View details ↗
NARecruitingNCT07275190

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

🏥 Fondazione IRCCS Policlinico San Matteo di Pavia📍 1 site📅 Started Jun 2025View details ↗
Phase 3RecruitingNCT07503730

Early Use of Realgar-Indigo Naturalis Formula (RIF) Combined With All-trans Retinoic Acid (ATRA) for Treating Acute Promyelocytic Leukemia (APL).

🏥 First Affiliated Hospital Xi'an Jiaotong University📍 1 site📅 Started Jun 2025View details ↗
NAEnrolling by InvitationNCT07013045

Comparing Structured Neuromuscular Exercise and Exergaming Program in Adolescents With Familial Mediterranean Fever

🏥 Istanbul University - Cerrahpasa📍 1 site📅 Started Jun 2025View details ↗
Phase 1, PHASE2RecruitingNCT06922591

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

👨‍⚕️ Maxim Pimpkin, MD, PhD, Tango Therapeutics, Inc.📍 12 sites📅 Started May 2025View details ↗
EARLY_Phase 1RecruitingNCT06765733

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy

👨‍⚕️ Yilong Wang, M.D., Beijing Tiantan Hospital, Capital Medical University, Beijing, China📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT03725670

Direct Lentiviral Injection Gene Therapy for MLD

👨‍⚕️ Lung-Ji Chang, Ph.D, Shenzhen Geno-Immune Medical Institute📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT06983366

Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases

👨‍⚕️ Ahmad M. Shaddad, MD, Assiut University📍 1 site📅 Started May 2025View details ↗
Phase 2RecruitingNCT06124157

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

👨‍⚕️ Thai Hoa Tran, Children's Oncology Group📍 139 sites📅 Started May 2025View details ↗
NARecruitingNCT06940960

JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia

👨‍⚕️ Jinqi Huang, PhD, Guangzhou First People's Hospital📍 1 site📅 Started May 2025View details ↗
Phase 1, PHASE2RecruitingNCT06533579

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

👨‍⚕️ Vironexis Clinical Trials, Vironexis Biotherapeutics Inc.📍 9 sites📅 Started May 2025View details ↗
Phase 2RecruitingNCT06302569

Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma

👨‍⚕️ Giuseppe Procopio, MD, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy📍 1 site📅 Started May 2025View details ↗
NARecruitingNCT07087873

Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases

🏥 Xuanwu Hospital, Beijing📍 1 site📅 Started May 2025View details ↗
← PreviousPage 105 of 519Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →